In Korean patients with AAA, the INCRAFT stent-graft system demonstrated favorable mid-term outcomes, with low rates of aneurysm-related mortality, acceptable reintervention rates, and stable aneurysm sac behavior.
I. Jin, Young-Guk Ko, Seung-Jun Lee et al.· Korean Circulation Journal· 0 citations
BACKGROUND AND OBJECTIVES
Peripheral arterial disease (PAD) is associated with intermittent claudication (IC), leading to a lower quality of life. Although Ginkgo biloba extract (GbE) has been investigated for the treatment of IC, its clinical efficacy remains controversial. This study aimed to evaluate the efficacy an...
Onyou Kim, Seung-Hun Lee, J. Kim et al.· Korean Circulation Journal· 0 citations
Background Twenty-four-hour ambulatory blood pressure monitoring (ABPM) is the reference standard for diagnosing hypertension and assessing treatment response, but routine use remains limited by conventional cuff-based devices. We compared 6-month ambulatory blood pressure (BP) between cuffless 24-hour ABPM-guided titr...
J. Cha, Mi-Na Kim, So Ree Kim et al.· Clinical Hypertension· 0 citations
Intra-individual change in Lp(a) between two measurements is independently associated with cardiovascular outcomes but provides only modest incremental discrimination, which requires prospective validation before they can inform repeat-testing strategies.
Mi-Na Kim, Dongkuk Kim, S. Hong et al.· Journal of Clinical Medicine· 0 citations
In patients with symptomatic PAD, the addition of cilostazol to rosuvastatin significantly improved patient-reported health status and provided additional favorable effects on atherogenic lipid profiles beyond rosuvastatin therapy alone.
A. Kemalasari, Dong-Woo Suh, I. Jin et al.· Cardiovascular Drugs and The...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.